Package 58657-810-21

Brand: pyridostigmine bromide

Generic: pyridostigmine bromide
NDC Package

Package Facts

Identity

Package NDC 58657-810-21
Digits Only 5865781021
Product NDC 58657-810
Product ID 58657-810_41b66d64-08b1-bd0c-e063-6394a90a5b86
Description

21 TABLET in 1 BOTTLE (58657-810-21)

Marketing

Marketing Status
Marketed Since 2019-06-01
Brand pyridostigmine bromide
Generic pyridostigmine bromide
Sample Package No

Linked Drug Pages (1)

Pyridostigmine Bromide ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "41b66d64-08b1-bd0c-e063-6394a90a5b86", "openfda": {"unii": ["KVI301NA53"], "rxcui": ["903841"], "spl_set_id": ["e756717f-941b-42f2-ba3b-03798c005ae7"], "manufacturer_name": ["Method Pharmaceuticals, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "21 TABLET in 1 BOTTLE (58657-810-21)", "package_ndc": "58657-810-21", "marketing_start_date": "20190601"}], "brand_name": "Pyridostigmine Bromide", "product_id": "58657-810_41b66d64-08b1-bd0c-e063-6394a90a5b86", "dosage_form": "TABLET", "pharm_class": ["Cholinesterase Inhibitor [EPC]", "Cholinesterase Inhibitors [MoA]"], "product_ndc": "58657-810", "generic_name": "PYRIDOSTIGMINE BROMIDE", "labeler_name": "Method Pharmaceuticals, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Pyridostigmine Bromide", "active_ingredients": [{"name": "PYRIDOSTIGMINE BROMIDE", "strength": "30 mg/1"}], "application_number": "ANDA211181", "marketing_category": "ANDA", "marketing_start_date": "20190601", "listing_expiration_date": "20261231"}